Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complications: neuropathy, pathogenetic considerations.

D A Greene1, A A Sima, M J Stevens

  • 1Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0354.

Diabetes Care
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Surgical Weight Loss on Cognition in Individuals with Class II/III Obesity.

The journal of nutrition, health & aging·2023
Same author

Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity.

Journal of diabetes and its complications·2021
Same author

Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease?

Experimental neurology·2019
Same author

Abnormal RNA stability in amyotrophic lateral sclerosis.

Nature communications·2018
Same author

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Journal of the peripheral nervous system : JPNS·2014
Same author

Integrated systems pharmacology analysis of clinical drug-induced peripheral neuropathy.

CPT: pharmacometrics & systems pharmacology·2014
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

Diabetic neuropathy, a common complication, involves nerve fiber damage linked to high blood sugar. Aldose reductase inhibitors (ARIs) show promise in normalizing nerve function and may offer future therapies.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetic neuropathy, particularly distal symmetric sensorimotor polyneuropathy, is a common complication of diabetes mellitus.
  • This condition involves nerve fiber atrophy, demyelination, and impaired regeneration, correlating with hyperglycemia severity and duration.
  • Proposed mechanisms include polyol pathway activation, leading to metabolic dysfunction and nerve conduction deficits.

Purpose of the Study:

  • To explore the metabolic underpinnings of diabetic neuropathy.
  • To investigate the role of hyperglycemia in nerve fiber damage.
  • To highlight potential therapeutic targets, such as aldose reductase inhibitors (ARIs).

Main Methods:

  • Review of proposed metabolic mechanisms in diabetic neuropathy pathogenesis.

Related Experiment Videos

  • Examination of the correlation between hyperglycemia and nerve damage in humans and animal models.
  • Discussion of the impact of polyol pathway activation and myo-inositol depletion on nerve function.

    • Main Results:

    • Hyperglycemia-induced activation of the polyol pathway leads to sorbitol/fructose accumulation and myo-inositol depletion.
    • This metabolic shift impairs nerve conduction by affecting Na(+)-K(+)-ATPase activity and osmoregulation.
    • Vascular insufficiency and nerve hypoxia also contribute to nerve fiber loss in diabetic neuropathy.

    Conclusions:

    • The polyol pathway and associated metabolic changes are key factors in diabetic neuropathy.
    • Aldose reductase inhibitors (ARIs) demonstrate potential for normalizing nerve myo-inositol levels and nerve conduction.
    • Further research is crucial to address remaining questions and develop comprehensive therapies for this complex condition.